ARCHIVES

In this 12-page issue: Moonlighting by NCI and FDA scientists conflicted with CRADA work, House Subcommittee on Oversight and Investigations says.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012

Study Finds Physician Referral By Centers Fraught With Problems, Potential Dangers

July 23, 1976

HHS Agency Says It Has No Jurisdiction And No Cause to Act on I-ELCAP Allegations

March 2, 2012

Study Sheds Light On How NSAIDS Prevent Colon Cancer

April 25, 2003

DCPC Board Approves Concept for New Nutrition Grants

February 10, 1989

UT Board Announces Support for MD Anderson Tenure System

October 10, 2014